再発性去勢抵抗性前立腺癌患者を対象としたGEN0101の第1相試験

基本情報

NCT ID: NCT02502994
ステータス: 不明
試験のフェーズ: 第1相
試験タイプ: 介入
目標被験者数: 12
治験依頼者名: Osaka University

概要

This study is designed to evaluate the safety and efficacy of a single injection of GEN0101 in patients with recurrence of castration resistant prostate cancer. The subjects receive GEN0101 injection 4 times per two weeks (1st intratumoral injection and followed subcutaneous injection) and two weeks of observation as one cycle treatment period. Each subject receive two cycle treatment period. Low dose group: 30,000m NAU per injection of GEN0101 High dose group: 60,000m NAU per injection of GEN0101 Each group included minimal 3 subjects.

対象疾患

Castration Resistant Prostate Cancer

介入

GEN0101(DRUG)

依頼者（Sponsor）

Norio Nonomura(OTHER)

実施施設 (1)

大阪大学医学部附属病院

Suita, Osaka, Japan(RECRUITING)